1. Home
  2. GLP vs NRIX Comparison

GLP vs NRIX Comparison

Compare GLP & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$46.47

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$22.10

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLP
NRIX
Founded
2005
2009
Country
United States
United States
Employees
4700
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GLP
NRIX
Price
$46.47
$22.10
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
$46.00
$30.50
AVG Volume (30 Days)
111.0K
2.9M
Earning Date
05-08-2026
04-08-2026
Dividend Yield
6.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,987,000.00
Revenue This Year
$64.13
N/A
Revenue Next Year
$11.74
$48.05
P/E Ratio
$23.28
N/A
Revenue Growth
N/A
99.31
52 Week Low
$39.58
$8.20
52 Week High
$53.42
$23.09

Technical Indicators

Market Signals
Indicator
GLP
NRIX
Relative Strength Index (RSI) 49.32 76.33
Support Level $45.18 $14.86
Resistance Level $46.51 $22.50
Average True Range (ATR) 2.22 1.61
MACD -0.07 0.61
Stochastic Oscillator 52.68 80.60

Price Performance

Historical Comparison
GLP
NRIX

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: